Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current developments and perspectives in psoriasis
Michael P. Schön, Dagmar Wilsmann‐Theis
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 4, pp. 363-372
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Exosomes: The emerging mechanisms and potential clinical applications in dermatology
Honghao Yu, Heting Feng, Hong Zeng, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1778-1795
Open Access | Times Cited: 21
Ameliorative effects of topical ramelteon on imiquimod-induced psoriasiform inflammation in mice
Ahmed Wahhab Mohammed Khafaji, Adeeb Ahmed Al-Zubaidy, Iqbal Farhood, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 6231-6248
Closed Access | Times Cited: 16
Mitigative Effects of Topical Norfloxacin on an Imiquimod-Induced Murine Model of Psoriasis
H. Salman, Elaf Mahmood Shihab, Hasanain Hasan, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 9, pp. 2739-2754
Open Access | Times Cited: 16
The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation
H. Salman, Adeeb A. Al-Zubaidy, Alaa Hamza Abbas, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 13
Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment
Luca Mastorino, Paolo Dapavo, Sara Susca, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 22, Iss. 1, pp. 34-42
Open Access | Times Cited: 20
Basic principles of artificial intelligence in dermatology explained using melanoma
Tim Hartmann, Johannes Passauer, Julien Hartmann, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 3, pp. 339-347
Open Access | Times Cited: 6
ART26.12, A FATTY ACID-BINDING PROTEIN 5 INHIBITOR, SHOWS EFFICACY IN PRECLINICAL PSORIASIS MODELS
W. G. Warren, Myles Osborn, Andrew Yates, et al.
Journal of Investigative Dermatology (2025)
Open Access
Vildagliptin topical ointment: an effective treatment for imiquimod-induced psoriasis in mice
B Ali, Ahmed R. Abu‐Raghif, Hayder Ridha‐Salman, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 3
Closed Access
Current and emerging prospects in the psoriatic treatment
Rutuja Vilas Nikam, M Gowtham, Pratiksha Sanjay More, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110331-110331
Closed Access | Times Cited: 10
Nanomedicine-Fortified Cosmeceutical Serums for The Mitigation of Psoriasis and Acne
Priya Patel, Rohit Pal, Krishna Butani, et al.
Nanomedicine (2023) Vol. 18, Iss. 24, pp. 1769-1793
Closed Access | Times Cited: 10
Mechanistic Investigation of WWOX Function in NF-kB-Induced Skin Inflammation in Psoriasis
Min‐Jeong Shin, Hyunsun A. Kim, Pyeongan Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 167-167
Open Access | Times Cited: 6
Biologikatherapie der Psoriasis in organtransplantierten Patienten
Alba Guglielmo, Alessandro Pileri, Pierluigi Toniutto, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 2, pp. 283-287
Closed Access | Times Cited: 1
Advancing psoriasis drug delivery through topical liposomes
Devesh U. Kapoor, Rahul Garg, Rahul Maheshwari, et al.
Zeitschrift für Naturforschung C (2024)
Closed Access | Times Cited: 1
A comprehensive overview of psoriatic research over the past 20 years: machine learning-based bibliometric analysis
Chenyang Yu, Yingzhao Huang, Wei Yan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Evolution of characteristics and biologic treatment effectiveness in patients of the Austrian psoriasis registry from 2004–2022
Thomas Graier, Wolfgang Salmhofer, Constanze Jonak, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 12, pp. 1513-1523
Open Access | Times Cited: 2
Machine learning (ML) techniques as effective methods for evaluating hair and skin assessments: A systematic review
Choudhary Sobhan Shakeel, Saad Jawaid Khan
Proceedings of the Institution of Mechanical Engineers Part H Journal of Engineering in Medicine (2023) Vol. 238, Iss. 2, pp. 132-148
Closed Access | Times Cited: 2
Drug survival und klinische Wirksamkeit von Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab und Tildrakizumab in der Behandlung der Psoriasis
Luca Mastorino, Paolo Dapavo, Sara Susca, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 1, pp. 34-44
Open Access
Grundprinzipien der künstlichen Intelligenz in der Dermatologie erklärt am Beispiel des Melanoms
Tim Hartmann, Johannes Passauer, Julien Hartmann, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 3, pp. 339-349
Open Access
Assessment of the anti-psoriasis effect of Scrophularia deserti methanolic extract in mice model
Raghad Abdulsalam Khaleel, Saja Majeed Shareef, Tayf Mohammed Maryoosh
ScienceRise Pharmaceutical Science (2024), Iss. 1(47), pp. 99-105
Open Access
Efficacy of glucagon‐like peptide‐1 receptor agonists for psoriasis: An updated systematic review and meta‐analysis
Su‐Chi Ku, Hua‐Ching Chang
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 8, pp. 1148-1152
Closed Access
Association between genetically proxied PPARG activation and psoriasis vulgaris: a Mendelian randomization study
Yan Xue, Yuning Xia, Donghao Cheng, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access
Alcohol abuse and discretionary habits in psoriatic patients: impact on IL‐17 and IL‐23 inhibitors response
Luca Mastorino, R. Daniele, Paolo Dapavo, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 9, pp. 1233-1241
Open Access
Wirksamkeit von Glucagon‐like Peptide‐1‐Rezeptor‐Agonisten bei Psoriasis: Eine aktualisierte systematische Übersicht und Metaanalyse
Su‐Chi Ku, Hua‐Ching Chang
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 8, pp. 1148-1152
Closed Access
Einfluss von Alkoholabusus und Lebensstil bei Patienten mit Psoriasis auf das Ansprechen auf IL‐17‐ und IL‐23‐Inhibitoren
Luca Mastorino, R. Daniele, Paolo Dapavo, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 9, pp. 1233-1242
Open Access
Entwicklung der Patientencharakteristika und der Wirksamkeit der Biologika‐Therapie bei Patienten des Österreichischen Psoriasis‐Registers von 2004 bis 2022
Thomas Graier, Wolfgang Salmhofer, Constanze Jonak, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 12, pp. 1513-1523
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top